Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes

Journal of Neuroimmunology

Volumn 96, Issue 2, 1999, Pages 234-240

  Ricci, Alberto ^b   Bronzetti, Elena ^b   Mignini, Fiorenzo ^a   Tayebati, Seyed Khosrow ^a   Zaccheo, Damiano ^c   Amenta, Francesco ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b Dipartimento di Scienze Demografiche   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Anti receptor antibodies; D1 receptor; D5 receptor; Dopamine receptors; Human; In situ hybridization cytochemistry; Peripheral blood lymphocytes

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOTOPE LABELING; LIGAND BINDING; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR BINDING; RNA ANALYSIS;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADULT; DOPAMINE ANTAGONISTS; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOMERISM; LYMPHOCYTES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; TRITIUM;

EID: 0033519291     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00042-9     Document Type: Article

References (35)

1. Ariano M.A., Sibley D.R. Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res. 27:1994;95-110.
2. Barili P., Bronzetti E., Felici L., Ferrante F., Ricci A., Zaccheo D., Amenta F. Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 71:1996;45-50.
3. Bergquist J., Silberring J. Identification of catecholamines in the immune system by electrospray ionization mass spectrometry. Commun. Mass. Spectrom. 12:1998;683-688.
4. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., Goldman-Rakic P.S. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15:1995;7821-7836.
5. Bondy B., de Jonge S., Pander S., Primbs J., Ackenheil M. Identification of dopamine D4 mRNA in circulating lymphocytes using nested polymerase chain reaction. J. Neuroimmunol. 71:1996;139-144.
6. Caronti B., Calderaro C., Passarelli F., Palladini G., Pontieri F.E. Dopamine receptor mRNAs in the rat lymphocytes. Life Sci. 62:1998;1919-1925.
7. Clark, B.A., 1990. Prejunctional dopamine receptor stimulants. In: Amenta, F. (Ed.), Peripheral Dopamine Pathophysiology. CRC Press, Boca Raton, pp. 267-306.
8. Defagot M.C., Malchiodi E.L., Villar M.J., Antonelli M.C. Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Mol. Brain Res. 45:1997;1-12.
9. Dijkstra C.D., van der Voort E.R., De Groot C.J., Huitinga I., Uitdehaag B.M., Polman C.H., Berkenbosch F. Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis. Psychoneuroendocrinology. 19:1994;135-142.
10. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135:1985;755s-765s.
11. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:1993;299-321.
12. Huang Q., Zhou D., Chase K., Gusella J.F., Aronin N., Di Figlia M. Immunohistochemical localization of D1 dopamine receptor in rat brain reveals its axonal transports, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. USA. 89:1992;11988-11992.
13. Josefsson E., Bergquist J., Ekman R., Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 88:1996;140-146.
14. Keller S.E., Weiss J.M., Schleiffer S.J., Miller N.E., Stein M. Stress-induced suppression of immunity in adrenalectomized rats. Science. 221:1983;1301-1304.
15. Laudenslager M.L., Ryan S.M., Drugan R.C., Hyson R.L., Maier S.F. Coping and immunosuppression-inescapable but not escapable shock suppressed lymphocyte proliferation. Science. 221:1983;568-570.
16. 3H ]-spiroperidol binding sites in mammalian lymphocytes Life Sci. 26:1980;1139-1148.
17. Levey A.L., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., Ciliax B.J. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. USA. 91:1993;8861-8865.
18. McPherson, G.A., 1994. RADLIG, Version 4. Biosoft, Cambridge.
19. Monjan, A.A., 1981. Stress and immunologic competence: studies in animals. In: R. Ader (Ed.), Psychoneuroimmunology. Academic Press, New York, pp. 185-194.
20. Morikawa K., Oseko F., Morikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95:1994;514-518.
21. Nagai Y., Ueno S., Saeki Y., Soga F., Yanagihara T. Expression of the D-3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 194:1993;368-374.
22. Nisticò G., Caroleo M.C., Arbitrio M., Pulvirenti L. Dopamine D1 receptors in the amygdala enhance the immune response in the rat. Ann. New York Acad. Sci. 741:1994;316-323.
23. Nisticò G., Caroleo M.C., Arbitrio M., Pulvirenti L. Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms. Neuroimmunomodulation. 1:1994;174-180.
24. Palmblad, J., 1981. Stress and immunologic competence: studies in man. In: R. Ader (Ed.), Psychoneuroimmunology. Academic Press, New York, pp. 229-236.
25. Qiu Y., Peng Y., Wang J. Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6:1996;223-231.
26. Ricci A., Amenta F. Dopamine D5 receptors in human peripheral blood lymphocytes: a radioligand binding study. J. Neuroimmunol. 53:1994;1-7.
27. 3H ]7-OH-DPAT J. Neuroimmunol. 58:1995;139-144.
28. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science. 212:1981;1100-1109.
29. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
30. Sklar L.S., Anisman H. Stress and cancer. Psychol. Bull. 89:1981;369-406.
31. Strange P.G. Dopamine receptors: studies on their structure and function. Adv. Drug Res. 28:1996;315-319.
32. Takahashi N., Nagai Y., Ueno S., Saeki Y., Yanagihara T. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudo genes. FEBS Lett. 314:1992;23-25.
33. Tsao C.W., Lin Y.S., Cheng J.T. Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci. 62:1998;. PL.
34. Vile J.M., Strange P.G. High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes. Biochem. Pharmacol. 49:1995;747-753.
35. 2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry. 40:1996;881-885.